{"entity":{"type":"insider","cik":"0001524803","url":"/insider/0001524803","json_url":"/insider/0001524803.json","name":"Stolz Brian M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2011-08-11","last":"2019-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Stolz Brian M.","source":"filing","n_filings":7,"first_seen":"2011-08-11","last_seen":"2019-08-15"}],"transactions":[{"id":8019970,"accession":"0001708989-19-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708989-19-000052","line_url":"/filing/0001708989-19-000052#line-2","is_derivative":false,"issuer_cik":"0000718877","issuer_name":"Activision Blizzard, Inc.","issuer_ticker":"ATVI","issuer_name_source":null,"issuer_url":"/issuer/0000718877","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.000001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134845.0,"shares_display":"134,845","price_per_share":47.7976,"price_display":"47.80","price_state":"stated","total_value":6445267.372,"total_display":"6,445,267.37","total_whole":"6,445,267","shares_owned_after":108041.0,"shares_owned_after_display":"108,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-15","scope":"insider"},{"id":5275143,"accession":"0000885590-13-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000071","line_url":"/filing/0000885590-13-000071#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Officer (EVP, Administration and CHCO)","role_mark":"O","role_mark_label":"Officer (EVP, Administration and CHCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Administration and CHCO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":100.7105,"price_display":"100.71","price_state":"stated","total_value":453197.25,"total_display":"453,197.25","total_whole":"453,197","shares_owned_after":32156.0,"shares_owned_after_display":"32,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-12","filed_date":"2013-08-12","scope":"insider"},{"id":2773017,"accession":"0000885590-12-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-12-000073","line_url":"/filing/0000885590-12-000073#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Officer (EVP, Administration and CHCO)","role_mark":"O","role_mark_label":"Officer (EVP, Administration and CHCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Administration and CHCO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2040.0,"shares_display":"2,040","price_per_share":52.756,"price_display":"52.76","price_state":"stated","total_value":107622.24,"total_display":"107,622.24","total_whole":"107,622","shares_owned_after":26650.0,"shares_owned_after_display":"26,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-07","filed_date":"2012-11-08","scope":"insider"},{"id":3407194,"accession":"0000885590-12-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-12-000027","line_url":"/filing/0000885590-12-000027#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Officer (EVP, Administration and CHCO)","role_mark":"O","role_mark_label":"Officer (EVP, Administration and CHCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Administration and CHCO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":53.1013,"price_display":"53.10","price_state":"stated","total_value":265506.5,"total_display":"265,506.50","total_whole":"265,507","shares_owned_after":20260.0,"shares_owned_after_display":"20,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-10","filed_date":"2012-05-14","scope":"insider"},{"id":9186704,"accession":"0000885590-11-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000078","line_url":"/filing/0000885590-11-000078#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Officer (EVP Administration & CHCO)","role_mark":"O","role_mark_label":"Officer (EVP Administration & CHCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Administration & CHCO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":42.05,"price_display":"42.05","price_state":"stated","total_value":100920.0,"total_display":"100,920.00","total_whole":"100,920","shares_owned_after":12860.0,"shares_owned_after_display":"12,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-17","filed_date":"2011-11-18","scope":"insider"},{"id":8894714,"accession":"0000885590-11-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000064","line_url":"/filing/0000885590-11-000064#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Officer (EVP, Administration and CHCO)","role_mark":"O","role_mark_label":"Officer (EVP, Administration and CHCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Administration and CHCO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2680.0,"shares_display":"2,680","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":109880.0,"total_display":"109,880.00","total_whole":"109,880","shares_owned_after":5230.0,"shares_owned_after_display":"5,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-26","filed_date":"2011-08-30","scope":"insider"},{"id":8916254,"accession":"0000885590-11-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-11-000054","line_url":"/filing/0000885590-11-000054#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Officer (EVP, Administration and CHCO)","role_mark":"O","role_mark_label":"Officer (EVP, Administration and CHCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Administration and CHCO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":39.2089,"price_display":"39.21","price_state":"stated","total_value":70576.02,"total_display":"70,576.02","total_whole":"70,576","shares_owned_after":2550.0,"shares_owned_after_display":"2,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-11","filed_date":"2011-08-11","scope":"insider"},{"id":8916252,"accession":"0000885590-11-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000054","line_url":"/filing/0000885590-11-000054#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001524803","owner_name":"Stolz Brian M.","owner_display_name":"Stolz Brian M.","owner_url":"/insider/0001524803","role":"Officer (EVP, Administration and CHCO)","role_mark":"O","role_mark_label":"Officer (EVP, Administration and CHCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Administration and CHCO","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":39.1006,"price_display":"39.10","price_state":"stated","total_value":29325.45,"total_display":"29,325.45","total_whole":"29,325","shares_owned_after":750.0,"shares_owned_after_display":"750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000718877","name":"Activision Blizzard, Inc.","url":"/issuer/0000718877","role":"Other","n_filings":1,"first_seen":"2019-08-15","last_seen":"2019-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Officer (EVP, Administration and CHCO)","n_filings":6,"first_seen":"2011-08-11","last_seen":"2013-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001524803","retrieved_at":"2026-08-24T01:02:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}